2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$579.55-$5.25 (-0.90%)
Price as of Oct 23, 2026 5:28 AM EDT- $25.1BMarket Cap
- 37.21%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$579.55-$5.25 (-0.90%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $584.79 | ||
Change | +$21.30 (+3.78%) | ||
Open | $568.69 | ||
High | $590.79 | ||
Low | $562.86 | ||
Previous Close | $563.49 | ||
Volume | 895,458 | ||
30-Day Average Volume | 880,323 | ||
1-Week Change | 7.99% | ||
1-Month Change | 17.52% | ||
1-Year Change | 37.21% | ||
3-Year Change | 159.41% | ||
5-Year Change | 206.16% | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $7.2B | ||
Market Cap | $25.1B | ||
Enterprise Value | $23.5B | ||
Period: QTR TTM FY | |||
Revenue | $783.3M | ||
Net Income | $333.0M | ||
Free Cash Flow | $205.6M | ||
EBIT | $372.7M | ||
EBITDA | $396.9M | ||
Net Working Capital | $2.9B | ||
EPS | $7.27 | ||
Enterprise Value/EBITDA | 59 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 4 | ||
P/E | 80 | ||
PEG | 3 | ||
Price/Free Cash Flow | 122 | ||
Price/Operating Cash Flow | 80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 09/23/2009 | ||
Earnings & Revenue